Medicare Enrolled
Dr. Haider Rahbar, MD
Urology Physician · Port Huron, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rahbar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rahbar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rahbar
Dr. Haider Rahbar is an urology physician in Port Huron, MI, with 12 years of NPI registration. Based on federal Medicare data, Dr. Rahbar performed 1,752 Medicare services across 1,286 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rahbar received a total of $3,705 from 37 pharmaceutical and/or device companies across 157 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rahbar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 29% volume in MI
$3,705 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,752
Medicare services
Top 29% in MI for urology physician
1,286
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~146 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
438 | $2 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
219 | $87 | $253 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $63 | $174 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 135 | $134 | $350 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
134 | $7 | $92 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $108 | $397 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
93 | $159 | $660 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
86 | $8 | $28 |
| Urinalysis, microscopic examination A laboratory test that examines a urine sample under a microscope to check for cells, crystals, bacteria, or other substances. |
73 | $3 | $33 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
61 | $62 | $222 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
47 | $99 | $467 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $75 | $287 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
30 | $25 | $126 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $139 | $367 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $41 | $115 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $83 | $1,076 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
15 | $39 | $1,192 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $117 | $602 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
11 | $11 | $63 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
10.0% medium
89.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,705
Total received (2018-2024)
Avg $529/year across 7 years
Top 40% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
157
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,579 (96.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$126 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$774
2023
$1,130
2022
$751
2021
$315
2020
$232
2019
$290
2018
$213
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$198
Merck Sharp & Dohme LLC
$123
C. R. Bard, Inc. & Subsidiaries
$85
Sumitomo Pharma America, Inc.
$81
Astellas Pharma US Inc
$74
PFIZER INC.
$59
Janssen Biotech, Inc.
$40
Becton, Dickinson and Company
$37
Teleflex LLC
$25
Endo Pharmaceuticals Inc.
$21
ABBVIE INC.
$18
Boston Scientific Corporation
$13
Top 3 companies account for 52.3% of 2024 payments
All-time payments by company (2018-2024) ›
Axonics, Inc.
$441
C. R. Bard, Inc. & Subsidiaries
$386
Rochester Medical Corporation
$378
Boston Scientific Corporation
$256
Astellas Pharma US Inc
$251
PFIZER INC.
$249
Merck Sharp & Dohme LLC
$242
Janssen Biotech, Inc.
$217
BOSTON SCIENTIFIC CORPORATION
$153
Sumitomo Pharma America, Inc.
$116
Myriad Genetic Laboratories, Inc.
$105
Teleflex LLC
$77
ABBVIE INC.
$67
UroGen Pharma, Inc.
$63
Medtronic USA, Inc.
$60
Tolmar, Inc.
$60
Endo Pharmaceuticals Inc.
$58
Coloplast Corp
$54
Amgen Inc.
$53
Janssen Scientific Affairs, LLC
$43
Becton, Dickinson and Company
$37
AstraZeneca Pharmaceuticals LP
$35
Vanda Pharmaceuticals Inc.
$34
180 Medical, Inc.
$31
Ambu Inc.
$25
Blue Earth Diagnostics Limited
$25
Myovant Sciences Inc.
$24
Accord Healthcare, Inc.
$22
Cook Medical LLC
$21
NeoTract Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$17
PROCEPT BioRobotics Corporation
$17
Medtronic, Inc.
$16
DENTSPLY IH AB
$15
TOLMAR Pharmaceuticals, Inc.
$13
UROGEN PHARMA, INC.
$13
ROCHESTER MEDICAL CORPORATION
$11
Top 3 companies account for 32.5% of all-time payments
Associated products mentioned in payments ›
AMS · AMS 700 · AQUABEAM ROBOTIC SYSTEM · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · ELIGARD · ERLEADA · Erleada · GEMTESA · HETLIOZ · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LOFRIC · LYNPARZA · LoFric · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · PROLARIS · Personal Catheter Intermittent Catheter · Porges Coloplast · Prolaris · Prolia · RESONANCE · Rezum Generator · SPIRIT · SpeediCath · UROLIFT · UroLift · XIAFLEX · XTANDI · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
6
Per 100K population
3.7
County median income
$69,349
Nearest hospital
LAKE HURON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rahbar is a clinical cardiology specialist, with above-average Medicare volume (top 29% in MI), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rahbar experienced with automated urinalysis?
Based on Medicare claims data, Dr. Rahbar performed 438 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rahbar receive payments from pharmaceutical companies?
Yes. Dr. Rahbar received a total of $3,705 from 37 companies across 157 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rahbar's costs compare to other urology physicians in Port Huron?
Dr. Rahbar's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rahbar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Port Huron
Browse urology physicians in Port Huron ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MI
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MI
Which MI urology physicians receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
C. R. Bard, Inc. & Subsidiaries Payments to Doctors
See all physicians who received payments from C. R. Bard, Inc. & Subsidiaries.
By company
Rochester Medical Corporation Payments to Doctors
See all physicians who received payments from Rochester Medical Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology